Windtree Therapeutics Inc (NASDAQ:WINT) Stock Jumps 7% in a Week: But Why?

Windtree Therapeutics Inc (NASDAQ:WINT) has been one of the stocks to have come into the attention of many investors in recent day and that is apparent from the sort of gains that have been clocked by its stock.

Over the course of the past week alone, the Windtree stock has been in the middle of a steady rally and has manage to deliver gains of 7% so far. Windtree is involved in both the biotech and medical device industries. At this point in time the company is focussing on the development on products that could help with interventions when it comes to pulmonary and cardiovascular disorders.

Yesterday, the company was in the news once again after it announced that it appointed Randall White as the new Vice President of Clinical Program Management. White is going to report directly to the Senior Vice President and Chief Medical Officer of the company Steve Simonson.

The announcement seems to have come as another boost for the market participants as the stock continued on its upward move yesterday. At this point, it might be a good idea for investors to keep a close eye on the developments around Windtree.